Furthermore, METTL3 promoted ferroptosis of SMCs by suppressing the expression of SLC7A11 and FSP1, and inhibiting ferroptosis largely reversed BAPN-induced AD in mice. This evidence concerns the gene SLC7A11 and Alzheimer disease.